2021 American Transplant Congress

TOPIC: Clinical Science

Breakthrough Cytomegalovirus DNAemia in High vs Intermediate Risk Heart Transplant Recipients
G. Huang¹, O. E. Beaird¹, M. Davis², M. Carlson¹, S. Chang¹, P. Gaynor¹, A. Fan², M. Deng³, A. Multani¹, A. Nsair³, J. Schaenman¹
Calcineurin Inhibitor Dose and Selection, Not Antiproliferatives or Steroids, Influence Development of DSA One Year Post-kidney Transplant
M. Henderson¹, G. Morris², L. Awdishu¹, K. Fabbri¹, M. Shah³, A. Khan³, J. Kerr¹
Can an Organ Survive for More Than 100 Years Between Donor and Recipient
R. Gruessner, J. Renz, A. C. Gruessner
Can Procurement Biopsy Data Tell Us Anything? The Influence of Glomerulosclerosis on Long-term Kidney Graft Survival
D. Stewart¹, L. Kamal², J. Foutz³, H. McGehee³, P. Saravanane², S. Yu², R. Yousfi², G. Gupta²
Can Procurement Biopsy Data Tell Us Anything? The Influence of Interstitial Fibrosis on Long-term Kidney Graft Survival
D. Stewart¹, J. Foutz¹, L. Kamal², H. McGehee¹, P. Saravanane², S. Yu³, R. Yousfi², G. Gupta²
Cancer Among Kidney Transplant Recipients More Than 20 Years After Transplantation: PTLD Remains the Most Common Cancer Type Even in the Very Long-Term
T. Schachtner, J. Fuhrmann, T. Mueller
Cancer-Specific Mortality in Solid Organ Transplant Recipients with a Prior Cancer Diagnosis
E. Engels¹, G. Haber¹, A. Hart², C. Lynch³, J. Li⁴, K. Pawlish⁴, B. Qiao⁵, K. Yu¹, R. Pfeiffer¹
Cardiac Outcomes in Isolated Heart and Simultaneous Kidney and Heart Transplants in the US
K. A. Agarwal¹, H. Patel¹, N. Agrawal¹, F. Cardarelli¹, N. Goyal²
Cardiac Risk Assessment in Liver Transplant Candidates: Survey of National Practice Patterns
P. Barman¹, R. Chadha², L. VanWagner³
CD40 Blockade by the Fc-Silent Immunosuppressive Antibody Iscalimab Results in Diminished B Cell Activation and Differentiation and is Paralleled by Whole Blood Gene Expression Data
R. Kraaijeveld¹, M. W. van den Hoogen¹, A. E. de Weerd¹, E. Ferroro², G. Robert², U. Laessing², B. Haraldsson², J. S. Rush², C. C. Baan¹